v3.25.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Other revenue $ 1,404 $ 0 $ 1,404 $ 0
Operating expenses:        
Research and development 192 1,361 603 3,752
General and administrative 915 1,462 2,408 2,778
Total operating expenses 1,107 2,823 3,011 6,530
Income (loss) from operations 297 (2,823) (1,607) (6,530)
Other income (expense):        
Interest income 31 52 62 100
Loss on settlement of common stock warrant liabilities 0 (185) 0 (759)
Change in fair value of warrant liabilities 1 255 16 139
Total other income (expense) 32 122 78 (520)
Net income (loss) 329 (2,701) (1,529) (7,050)
Net loss attributable to non-controlling interests (6) (9) (12) (18)
Net income (loss) attributable to Avenue 335 (2,692) (1,517) (7,032)
Net income (loss) attributable to common stockholders $ 335 $ (7,186) $ (1,517) $ (15,842)
Weighted average number of common shares outstanding, basic and diluted (in shares) 3,183,558 1,117,769 3,077,704 839,900

Source